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Background: The infraorbital nerve (ION) is a terminal
branch of the maxillary nerve (V2) providing sensory in-
nervation to the malar skin. It is sometimes necessary to
sacriﬁce the ION and its branches to obtain adequate
maxillary sinus exposure for radical resection of sinonasal
tumors. Consequently, patients suﬀer temporary or perma-
nent paresthesia, hypoestesthia, and neuralgia of the face.
We describe an innovative technique used for preservation
of the ION while removing the anterior, superior, and lateral
walls of the maxillary sinus through a medial endoscopic
transnasal maxillectomy.
Methods: All patients who underwent transnasal endo-
scopic maxillectomy with ION transposition in our institute
were retrospectively reviewed.
Results: Two patients were identiﬁed who had been
treated for sinonasal cancers using this approach. No major
complications were observed. Transient loss of ION func-
tion was observed with complete recovery of skin sen-
sory perception within 6 months of surgery. One patient
referred to a mild permanent anesthesia of the upper in-
cisors. No diplopia or enophthalmos were encountered in
any of the patients.
Conclusion: The ION transposition is useful for selected
cases of benign and malignant sinonasal tumors that do not
inﬁltrate the ION itself but involve the surrounding portion
of the maxillary sinus. Anatomic preservation of the ION
seems to be beneﬁcial to the postoperative quality of life
of such patients. C© 2016 ARS-AAOA, LLC.
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T he infraorbital nerve (ION) is a terminal branch of themaxillary nerve (V2)1 originating in the pterygopala-
tine fossa once the latter exits the skull base through the
rotundum foramen. The ION then enters the inferior orbital
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fissure and runs on the floor of the orbit via the infraorbital
canal, reaching the infraorbital foramen anteriorly. It is re-
sponsible for sensory innervation to the skin of the malar
area between the lower eyelid and the upper lip.
Injury to the ION may lead to temporary or permanent
paresthesia, hypoestesthia, and neuralgia of the face.2 Tra-
ditionally, the maxillary sinus has been accessed by way of
external approaches such as those described by Caldwell3
and Luc,4 lateral rhinotomy, and the midfacial degloving
approach.5 However, in the course of such approaches, es-
pecially during removal of the maxillary roof, there occurs
the possibility of ION damage.
Over the last decade the transnasal endoscopic maxil-
lectomy has been validated as the standard treatment for
most benign6 and some selected malignant tumors of the
sinonasal tract arising from or extending to the maxillary
sinus.7–12 It avoids external incisions and the major com-
plications resulting from traditional approaches. Neverthe-
less, in some cases, the sacrifice of the ION and its branches
may be necessary for adequate sinus exposure and radical
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resection of tumors. In this report we describe the endo-
scopic transnasal ION transposition, an innovative tech-
nique used for preservation of the nerve during removal of
the anterior wall, the roof, and part of the lateral wall of
the maxillary sinus, after a medial maxillectomy.
Surgical Technique
Preparation
The extent of the patient’s disease is assessed preoperatively
using nasal endoscopy and radiologic studies, which in-
cludes computed tomography (CT) and contrast-enhanced
magnetic resonance (MR). Patients with a diagnosis of ma-
lignant tumor complete their staging with a total body CT
scan and neck ultrasound. Surgery is performedwith the pa-
tient under hypotensive general anesthesia. The nasal cavi-
ties are packed with pledges soaked in a 2% oxymetazoline,
1% oxybuprocaine, and epinephrine (1/100,000) solution,
for 10 minutes. Rod lens 0- and 45-degree endoscopes of
4 mm diameter are used (Karl Storz, Tuttlingen, Germany).
Exposure
A wide middle meatal antrostomy is performed to expose
the maxillary sinus and intramaxillary landmarks such as
the posterior wall of the maxillary sinus, the ION, and the
inferomedial angle of the orbit. After complete ethmoidec-
tomy, a wide sphenoidotomy is performed to identify the
intrasphenoidal impression of V2, which is the inferior
limit of the cavernous sinus. The turbinal branches of the
sphenopalatine artery are identified and cauterized to pre-
vent bleeding. A vertical mucosal incision is performed with
a diode laser along the maxillary line from the insertion of
the middle turbinate down to the nasal floor. From this
point, a second mucosal incision is continued posteriorly in
the inferior meatus, to as far as the junction between the
soft and hard palate. The nasolacrimal duct is isolated and
transected below the sac and the medial wall of the maxil-
lary sinus with the inferior turbinate is removed. During the
inferior osteotomy, it is important to identify the junction
between the palatine bone and the posterior maxillary wall
to avoid injury to the descending palatine artery.
The nasal vestibule is incised in a vertical slightly curved
fashion, exposing the bone of the pyriform aperture. The
periosteum and soft tissue enveloping the anterior wall of
maxillary sinus are dissected with an elevator as far as the
infraorbital foramen. The pyriform crest is drilled out with
a diamond burr. The anterior wall of the maxillary sinus is
removed as far as the ION, or even more laterally. Usually,
the superior limit of the dissection is determined by the
horizontal plane passing through the infraorbital foramen,
so as to avoid injury to the ION and violation of the orbital
content.
The posterior wall of the maxillary sinus is drilled out
and then removed with Kerrison roungers in a medial-to-
lateral direction, thus exposing the periosteal layer of the
pterygopalatine and infratemporal fossa.13 The foramen
FIGURE 1. Anatomic diagram showing the position of the endoscope and
surgical instruments, after endoscopic transnasal partial maxillectomy. The
infraorbital nerve has been completely skeletonized, from the foramen ro-
tundum to the premaxillary soft tissues. FR = foramen rotundum; ION =
infraorbital nerve; ZB = zygomatic bone.
rotundum and V2 are identified laterally and superior to
the vidian nerve. The inferomedial angle of the orbit and
the superior wall of the maxillary sinus are then removed
to unroof the ION from its exit at the rotundum foramen
to its emergence on the soft tissues of the premaxillary
region. Once the bony infraorbital canal is completely
removed and the ION is skeletonized, it is possible to
transpose the nerve, thus allowing removal of the portion
of the orbital floor placed laterally to the ION course.
This approach also makes it possible to reach the lateral
wall of the maxillary sinus, which can be drilled out
as far as the zygomatic arch when necessary (Figure 1).
These deep-lateral walls of maxillary sinus are removed by
drilling out the bone, obtaining a thin, bony shell that is
finally removed with curved dissectors. At the end of the
procedure, what remains intact is the inferior maxillary
wall and the residual portion of the lateral one. The mucosa
over these walls is completely removed using curved and
double curved dissectors as well as small cotton pledges.
Case 1
A 60-year-old man presented with swelling of the left max-
illa and epistaxis for a poorly differentiated squamous cell
carcinoma of the left maxillary sinus. At our center, the
treatment protocol for poorly differentiated epithelial tu-
mors of the sinonasal tract includes induction chemother-
apy to separate responder patients, who are candidates
for concurrent chemoradiation, and nonresponder patients,
who are candidates for multimodal therapy.14,15 The pa-
tient was therefore submitted for induction chemotherapy
(TPF scheme). The contrast-enhanced MR scan performed
after treatment showed a lack of response to induction
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FIGURE 2. Preoperative axial (A) and coronal (B) magnetic resonance imaging with contrast enhancement showing the persistence of a left maxillary
squamous cell carcinoma (case 1) eroding the anterior wall of the sinus (yellow arrows) without soft tissue involvement. Postoperative contrast-enhanced
magnetic resonance imaging with axial view (C) demonstrates the radical resection of the tumor. The isointense signal on the surgical bed is compatible with
scar tissue related to the surgical procedure, given the lack of contrast enhancement uptake. The postoperative coronal CT scan (D) highlights the removal of
the bony orbital floor and the inferomedial angle of the orbit (left side). Herniation of the orbital content and the enophthalmos are avoided by preserving the
periobital layer.
chemotherapy, with a persistent lesion in the left maxillary
sinus (Figure 2A and B).
After a multidisciplinary tumor board discussion, the pa-
tient was submitted for surgery using an endoscopic en-
donasal approach. A left transnasal medial maxillectomy
was extended to the anterior and superior wall of the
maxillary sinus. During the operation the ION transpo-
sition was performed as previously described (Figure 3).
Intraoperative frozen sections of the surgical margins con-
firmed the radical resection of the tumor while preserv-
ing the ION. The patient was discharged 4 days after
surgery complaining of only mild paresthesia and hypoes-
thesia of the upper lip and upper teeth. The final histol-
ogy report diagnosed poorly differentiated squamous cell
carcinoma, staged yT3N0M0, and confirmed the radical
resection of the tumor. Adjuvant intensity–modulated ra-
diotherapy (IMRT) was delivered on the surgical cavity
(66 Gy) as well as to the neck lymph nodes (levels from
1 to 3 on the left side and retropharyngeal nodes, 54 Gy).
The postoperative contrast-enhancedMR and CT scan per-
formed 1 year after the multimodal treatments confirmed
the radical resection of the tumor (Figure 2C and D), and
endoscopic evaluation showed complete healing of the sur-
gical cavity (Figure 4). After a 15-month follow-up, the
patient is free of disease and ION function was completely
restored. No diplopia or enophthalmos were encountered.
Case 2
An 80-year-old man presented with right epistaxis recur-
rent over 1 year. He was a retired woodworker. The CT
scan and the contrast-enhanced MR scan revealed a right
sinonasal mass involving the ethmoid cells and right max-
illary sinus (medial wall). Neck ultrasound and total body
positron emission tomography CT scan ruled out any sys-
temic dissemination of disease. The biopsy of the lesion
indicated compatibility with an intestinal-type adenocarci-
noma, signet-ring cells variant. The patient was submitted
for an endoscopic resection with transnasal craniectomy
extended bilaterally to both the ethmoid complexes and in-
cluding removal of the nasal septum. Intraoperative frozen
sections were positives at the medial, anterior, and lateral
maxillary walls and therefore an expanded transnasal max-
illectomy with transposition of the IONwas performed (see
Video 1 and Video 2 in Supplementary Materials). The an-
terior skull base was repaired with fascia lata in amultilayer
fashion. The final histology report confirmed radical resec-
tion of the lesion and staged the tumor as pT3N0M0. Adju-
vant IMRT (62 Gy) was then delivered on the surgical bed.
The contrast-enhanced MR scan performed 6 months after
treatment excluded local recurrences of disease. Restora-
tion of ION function was achieved within 6 months of
surgery, with only a mild anesthesia of the upper incisors
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FIGURE 3. Step-by-step endoscopic endonasal infraorbital nerve transpo-
sition (case 1). (A) Intraoperative view after performing an endoscopic en-
donasal medial maxillectomy (left side) with removal of the pyriform aper-
ture and the bony anterior maxillary wall. (B) The infraorbital nerve was
unroofed from its canal as far as its emergence on the premaxillary soft tis-
sues. (C) A high-speed diamond burr is used to drill out the bony floor of the
orbit laterally to the infraorbital nerve course as well as the lateral maxillary
wall. A dissector is used to elevate and displace the skeletonized infraorbital
nerve. (D) Final endoscopic endonasal view of the infraorbital nerve when
fully isolated. AWM = anterior wall of the maxillary sinus; ION = infraor-
bital nerve; LWM = lateral wall of the maxillary sinus; OF = orbital floor;
PWM = posterior wall of the maxillary sinus; SCT = subcutaneous tissues of
the premaxillary region. The white asterisk shows the tumor.
FIGURE 4. Postoperative endoscopic view of the maxillary cavity 1 year
after endoscopic transnasal partial maxillectomy.
related to the injury of the anterior superior alveolar nerve.
No diplopia or enophthalmos were encountered.
Discussion
Traditional external surgical techniques are generally used
for tumors extensively involving the maxillary sinus with
erosion of its lateral and/or inferior walls. However,
they are associated with complications such as epiphora,
dental pain, dacryocysitis, mucocele, external scarring,
paresthesia in the V2 territory, and cosmetic deformity.
Consequently, they should be reserved only for selected tu-
mors that are not amenable to less invasive approaches.
All these surgical techniques may cause injury to the ION.
Damage to this nerve results in paresthesia, hypoesthe-
sia, and neuralgia of the skin of the lower eyelid, cheek,
nasal ala, lip (skin and mucosa), alveolar mucosa, and
gums.16
Recent literature describing the endoscopic medial max-
illectomy and its variations for approaching the maxillary
sinus has endorsed this method as a successful treatment
for inflammatory conditions as well as for benign lesions
and certain selected malignant tumors. We present an al-
ternative method for approaching the anterior and lat-
eral portion of the maxillary sinus through an endoscopic
assisted endonasal approach in which the ION is skele-
tonized, transposed, and thus preserved. This technique is
useful for selected cases of benign and malignant tumors
of the maxillary sinus that do not infiltrate the ION itself
but involve the surrounding portion of the maxillary sinus
(mucosa of the anterior, superior and lateral walls). In our
experience with this approach, we have observed only tran-
sitory loss of function of the ION, with complete restora-
tion of the skin’s sensory perception within 6 months of
surgery. In only 1 patient (case 2), a mild anesthesia of the
upper incisors was observed. This was probably related to
the intraoperative injury of the anterior superior alveolar
nerve, a collateral branch of the ION. Regarding the possi-
bility of orbital sequelae, the integrity of the periorbit does
not allow the orbital content to expand and protects the pa-
tient from diplopia and enophthalmos, thus no reconstruc-
tion of the orbital walls is required.17,18 This approach is
contraindicated for adenoid cystic carcinomas of the maxil-
lary sinus, given their high propensity for perineural spread,
as well as for malignant tumors directly invading the ION
canal or infiltrating the nerve itself. Here, the resection of
the ION, including the skin with the cutaneous branches
of the ION affected, is mandatory to obtain a radical
resection.
To the best of our knowledge, this is the first report de-
scribing transposition of the ION during an endoscopic
endonasal approach for resection of lesions involving the
maxillary sinus. In conclusion, the ION transposition dur-
ing expanded endoscopic endonasal approaches is a fea-
sible and minimally invasive technique for addressing the
anterior and lateral portion of the maxillary sinus in well-
selected cases. Anatomic preservation of the ION seems
to offer benefits to the postoperative quality of life of
such patients. Further functional studies are necessary to
quantitatively evaluate tactile, thermic, and pain sensi-
tivity, and to prove the real benefits of this technique
compared with traditional external approaches for ap-
proaching the anterior and lateral aspects of the maxillary
sinus.
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